Efficacy of erythropoietin beta pegol assessment study with kidney diseases. - EPACME Study (ErythroPoietin Assessment in CKD patients by Metabolic and Endocrinological factors)

Kyoto University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2012年3月13日最近更新: 2023年10月17日

适应症

试验速览

暂无简介。

•1. patients with uncontrolled hypertension (SBP >=180mmHg, DBP >= 110mmHg) 2. patients with critical cardiac and/or vascular complications 3. patients whose Hb level must be maintained less than 12.0 g/dL 4. patients who needs blood transfusion 5. patients with anemia other than renal anemia 6. patients with liver dysfunction [GPT(ALT) over three times the normal value] 7. patients with malignancies under current treatment 8. pregnant or breast feeding female patients, including one trying to conceive pregnancy during the planned study period 9. patients with uncontrolled arrhythmia 10. patients with cardiac insufficiency (NYHA grade III or IV) 11. patients with a history of hypersensitivity to ingredients of epoetin alpha, epoetin beta, darbopoetin alpha 13. patients who are considered not eligible for the study by the attending doctor due to medical reasons

发起方

Kyoto University Graduate School of Medicine